Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Microbiology Spectrum
|
June 25, 2024
Absolute quantification of viral proteins from pseudotyped VSV-GP using UPLC-MRM
Rajeswari Basu, Richard Dambra, Di Jiang, et al.
Journal of Virology
|
December 26, 2014
Intracellular expression of camelid single-domain antibodies specific for influenza virus nucleoprotein uncovers distinct features of its nuclear localization
Joseph Ashour, Florian I Schmidt, Leo Hanke, et al.
Cell Host & Microbe
|
November 19, 2013
Type I interferon imposes a TSG101/ISG15 checkpoint at the Golgi for glycoprotein trafficking during influenza virus infection
Sumana Sanyal, Joseph Ashour, Takeshi Maruyama, et al.
Cell Host & Microbe
|
November 16, 2010
Mouse STAT2 restricts early dengue virus replication
Joseph Ashour, Juliet Morrison, Maudry Laurent-Rolle, et al.
Nature Communications
|
October 16, 2020
Lyn kinase regulates egress of flaviviruses in autophagosome-derived organelles
Ming Yuan Li, Trupti Shivaprasad Naik, Lewis Yu Lam Siu, et al.
Molecular Therapy. Methods & Clinical Development
|
March 14, 2025
Characterization of VSV-GP morphology by cryo-EM imaging and SEC-MALS
Dongyue Xin, Leela Kurien, Katherine Briggs, et al.
The Journal of Biological Chemistry
|
January 31, 2013
Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza A virus
Gabriel L Hendricks, Kim L Weirich, Karthik Viswanathan, et al.
Nature
|
October 22, 2013
Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virus
Stephanie K Dougan, Joseph Ashour, Roos A Karssemeijer, et al.
Journal of Virology
|
January 29, 2010
The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling
Maudry Laurent-Rolle, Elena F Boer, Kirk J Lubick, et al.
Molecular Therapy. Methods & Clinical Development
|
January 26, 2023
Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replication
Richard Dambra, Andrea Matter, Kaitlynn Graca, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Microbiology Spectrum
|
June 25, 2024
Absolute quantification of viral proteins from pseudotyped VSV-GP using UPLC-MRM
Rajeswari Basu, Richard Dambra, Di Jiang, et al.
Journal of Virology
|
December 26, 2014
Intracellular expression of camelid single-domain antibodies specific for influenza virus nucleoprotein uncovers distinct features of its nuclear localization
Joseph Ashour, Florian I Schmidt, Leo Hanke, et al.
Cell Host & Microbe
|
November 19, 2013
Type I interferon imposes a TSG101/ISG15 checkpoint at the Golgi for glycoprotein trafficking during influenza virus infection
Sumana Sanyal, Joseph Ashour, Takeshi Maruyama, et al.
Cell Host & Microbe
|
November 16, 2010
Mouse STAT2 restricts early dengue virus replication
Joseph Ashour, Juliet Morrison, Maudry Laurent-Rolle, et al.
Nature Communications
|
October 16, 2020
Lyn kinase regulates egress of flaviviruses in autophagosome-derived organelles
Ming Yuan Li, Trupti Shivaprasad Naik, Lewis Yu Lam Siu, et al.
Molecular Therapy. Methods & Clinical Development
|
March 14, 2025
Characterization of VSV-GP morphology by cryo-EM imaging and SEC-MALS
Dongyue Xin, Leela Kurien, Katherine Briggs, et al.
The Journal of Biological Chemistry
|
January 31, 2013
Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza A virus
Gabriel L Hendricks, Kim L Weirich, Karthik Viswanathan, et al.
Nature
|
October 22, 2013
Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virus
Stephanie K Dougan, Joseph Ashour, Roos A Karssemeijer, et al.
Journal of Virology
|
January 29, 2010
The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling
Maudry Laurent-Rolle, Elena F Boer, Kirk J Lubick, et al.
Molecular Therapy. Methods & Clinical Development
|
January 26, 2023
Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replication
Richard Dambra, Andrea Matter, Kaitlynn Graca, et al.
Page
of 3